Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium? Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery. Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
Study Completion
Last participant's last visit for all outcomes
July 1, 2028
February 9, 2026
February 1, 2026
1.8 years
July 30, 2024
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Pain Score: Numeric Pain Scale
Short and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.
Through study completion, up to 1 year
Rate of abnormal respiratory mechanics: Incentive Spirometry
Through study completion, up to 1 year
Rate of abnormal respiratory mechanics: Pulmonary Function Tests
Short and Long Term Respiratory Mechanics. Pulmonary Function Tests will specifically measure Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC)
Through study completion, up to 1 year
Rate of delirium: Confusion Assessment Method (CAM) Score
The score ranges from 0 to 19. Where higher scores indicate more severe delirium and low scores indicate less severe or no delirium
Through study completion, up to 1 year
Quality of Life on Survey
Long Term Quality of Life
Through study completion, up to 1 year
Secondary Outcomes (9)
Rate of Pneumonia
Through study completion, up to 1 year
Rate of need for Intubation/Mechanical Ventilation
Through study completion, up to 1 year
Rate of need for tracheostomy
Through study completion, up to 1 year
Number of Ventilatory Days
Through study completion, up to 1 year
ICU Length of Stay
Through study completion, up to 1 year
- +4 more secondary outcomes
Study Arms (2)
Standard multi-modal pain regimen alone
PLACEBO COMPARATORStandard multi-modal pain regimen with percutaneous cryoablation
EXPERIMENTALInterventions
Percutaneous Cryoablation of Intercostal Nerves
Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)
Eligibility Criteria
You may qualify if:
- \> 18 years old
- \> 2 rib fractures
- Verbal Pain score \> 5
- Incentive Spirometry \< 60% of predicted
You may not qualify if:
- Isolated Fractures of Ribs 1-3 and/or 10-12
- Posterior Rib Fracture \< 4 cm from costovertebral joint
- Sternal, Clavicle, Scapula Fracture
- Thoracic Spinal Fracture of any type
- Open Abdominothoracic Surgery
- Unstable Spine
- Extensive Subcutaneous Emphysema
- BMI \> 35
- Plan for Rib Plating
- Chronic Opioid Use
- Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy
- Coagulopathy, Shock at time of ablation
- Inability to participate in activities of daily living prior to injury
- Home O2 use prior to trauma
- Inhalation Injury
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University Health
Loma Linda, California, 92354, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 1, 2024
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
February 9, 2026
Record last verified: 2026-02